Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Asthma Exacerbations: later-stage trial registry

1 of 1 indexed Asthma Exacerbations trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Asthma Exacerbations: 1 US clinical trial tracked, 1 recruiting.

Asthma Exacerbations is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is DARTNet Institute, running 1 of these trials.

Enrollment posture brief

Registry condition asthma-exacerbations

OPEN 1 | RECR 100% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Asthma Exacerbations (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Asthma Exacerbations

Asthma Exacerbations lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Asthma Exacerbations on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Asthma Exacerbations is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Top Sponsors

Named interventions

Most-linked intervention names on Asthma Exacerbations records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Asthma Symptom Monitoring Web-based Application Other
1 trials
Inhaled corticosteroid (ICS) Drug
1 trials
Azithromycin Drug
1 trials

US sites by state

Facility locations filed on Asthma Exacerbations trials. A trial with sites in several states counts in each.

Washington 1 trials
Texas 1 trials
New York 1 trials
New Jersey 1 trials
North Carolina 1 trials
Missouri 1 trials
Massachusetts 1 trials
Kansas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Asthma Exacerbations page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Asthma Exacerbations trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • DARTNet Institute sponsors the most Asthma Exacerbations trials on record, review their full trial history before evaluating a specific study. See DARTNet Institute's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Asthma Exacerbations condition card totals 1 registered trials; most-linked intervention Asthma Symptom Monitoring Web-based Application; top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.